PROTO LABS INC (PRLB) Stock Fundamental Analysis

NYSE:PRLB • US7437131094

62.63 USD
-0.65 (-1.03%)
At close: Feb 25, 2026
62.63 USD
0 (0%)
After Hours: 2/25/2026, 4:15:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to PRLB. PRLB was compared to 130 industry peers in the Machinery industry. PRLB has a great financial health rating, but its profitability evaluates not so good. PRLB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year PRLB was profitable.
  • In the past year PRLB had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: PRLB reported negative net income in multiple years.
  • PRLB had a positive operating cash flow in 4 of the past 5 years.
PRLB Yearly Net Income VS EBIT VS OCF VS FCFPRLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

  • The Return On Assets of PRLB (1.96%) is comparable to the rest of the industry.
  • The Return On Equity of PRLB (2.23%) is worse than 60.77% of its industry peers.
  • PRLB has a worse Return On Invested Capital (2.11%) than 67.69% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for PRLB is significantly below the industry average of 10.27%.
Industry RankSector Rank
ROA 1.96%
ROE 2.23%
ROIC 2.11%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
PRLB Yearly ROA, ROE, ROICPRLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • With a Profit Margin value of 2.86%, PRLB perfoms like the industry average, outperforming 43.85% of the companies in the same industry.
  • PRLB's Profit Margin has declined in the last couple of years.
  • The Operating Margin of PRLB (4.35%) is worse than 63.85% of its industry peers.
  • In the last couple of years the Operating Margin of PRLB has declined.
  • PRLB's Gross Margin of 44.12% is amongst the best of the industry. PRLB outperforms 83.85% of its industry peers.
  • PRLB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.35%
PM (TTM) 2.86%
GM 44.12%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
PRLB Yearly Profit, Operating, Gross MarginsPRLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

8

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRLB is destroying value.
  • There is no outstanding debt for PRLB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PRLB Yearly Shares OutstandingPRLB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
PRLB Yearly Total Debt VS Total AssetsPRLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • PRLB has an Altman-Z score of 11.23. This indicates that PRLB is financially healthy and has little risk of bankruptcy at the moment.
  • PRLB's Altman-Z score of 11.23 is amongst the best of the industry. PRLB outperforms 95.38% of its industry peers.
  • PRLB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 11.23
ROIC/WACC0.23
WACC9.18%
PRLB Yearly LT Debt VS Equity VS FCFPRLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

  • PRLB has a Current Ratio of 3.24. This indicates that PRLB is financially healthy and has no problem in meeting its short term obligations.
  • PRLB has a Current ratio of 3.24. This is in the better half of the industry: PRLB outperforms 80.00% of its industry peers.
  • A Quick Ratio of 3.04 indicates that PRLB has no problem at all paying its short term obligations.
  • The Quick ratio of PRLB (3.04) is better than 86.92% of its industry peers.
Industry RankSector Rank
Current Ratio 3.24
Quick Ratio 3.04
PRLB Yearly Current Assets VS Current LiabilitesPRLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

  • PRLB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.23%.
  • PRLB shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.99% yearly.
EPS 1Y (TTM)1.23%
EPS 3Y3.23%
EPS 5Y-6.99%
EPS Q2Q%15.79%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.11%

3.2 Future

  • Based on estimates for the next years, PRLB will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.23% on average per year.
  • Based on estimates for the next years, PRLB will show a small growth in Revenue. The Revenue will grow by 5.29% on average per year.
EPS Next Y2.56%
EPS Next 2Y9.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.87%
Revenue Next 2Y5.29%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PRLB Yearly Revenue VS EstimatesPRLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
PRLB Yearly EPS VS EstimatesPRLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

1

4. Valuation

4.1 Price/Earnings Ratio

  • PRLB is valuated quite expensively with a Price/Earnings ratio of 37.96.
  • Based on the Price/Earnings ratio, PRLB is valued a bit more expensive than 62.31% of the companies in the same industry.
  • PRLB's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.98.
  • With a Price/Forward Earnings ratio of 37.01, PRLB can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, PRLB is valued a bit more expensive than the industry average as 64.62% of the companies are valued more cheaply.
  • PRLB's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 28.01.
Industry RankSector Rank
PE 37.96
Fwd PE 37.01
PRLB Price Earnings VS Forward Price EarningsPRLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 63.85% of the companies in the same industry are cheaper than PRLB, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of PRLB indicates a somewhat cheap valuation: PRLB is cheaper than 68.46% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.9
EV/EBITDA 23.91
PRLB Per share dataPRLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PRLB does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)14.85
PEG (5Y)N/A
EPS Next 2Y9.23%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for PRLB!.
Industry RankSector Rank
Dividend Yield 0%

PROTO LABS INC

NYSE:PRLB (2/25/2026, 4:15:00 PM)

After market: 62.63 0 (0%)

62.63

-0.65 (-1.03%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-06
Earnings (Next)04-30
Inst Owners94.33%
Inst Owner Change0%
Ins Owners1.08%
Ins Owner Change0.61%
Market Cap1.48B
Revenue(TTM)N/A
Net Income(TTM)14.84M
Analysts78.18
Price Target57.8 (-7.71%)
Short Float %2.21%
Short Ratio2.88
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.68%
Min EPS beat(2)17.55%
Max EPS beat(2)17.81%
EPS beat(4)4
Avg EPS beat(4)15.66%
Min EPS beat(4)10.87%
Max EPS beat(4)17.81%
EPS beat(8)8
Avg EPS beat(8)23.41%
EPS beat(12)12
Avg EPS beat(12)26.01%
EPS beat(16)15
Avg EPS beat(16)25.13%
Revenue beat(2)1
Avg Revenue beat(2)1.29%
Min Revenue beat(2)-0.84%
Max Revenue beat(2)3.41%
Revenue beat(4)2
Avg Revenue beat(4)0.49%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)3.41%
Revenue beat(8)4
Avg Revenue beat(8)0.18%
Revenue beat(12)7
Avg Revenue beat(12)0.91%
Revenue beat(16)8
Avg Revenue beat(16)0.39%
PT rev (1m)0%
PT rev (3m)13.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)2.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE 37.96
Fwd PE 37.01
P/S 2.86
P/FCF 21.9
P/OCF 19.68
P/B 2.23
P/tB 4
EV/EBITDA 23.91
EPS(TTM)1.65
EY2.63%
EPS(NY)1.69
Fwd EY2.7%
FCF(TTM)2.86
FCFY4.57%
OCF(TTM)3.18
OCFY5.08%
SpS21.89
BVpS28.07
TBVpS15.68
PEG (NY)14.85
PEG (5Y)N/A
Graham Number32.28
Profitability
Industry RankSector Rank
ROA 1.96%
ROE 2.23%
ROCE 3.28%
ROIC 2.11%
ROICexc 2.56%
ROICexgc 5.3%
OM 4.35%
PM (TTM) 2.86%
GM 44.12%
FCFM 13.06%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
ROICexc(3y)2.8%
ROICexc(5y)3.78%
ROICexgc(3y)5.45%
ROICexgc(5y)6.71%
ROCE(3y)3.77%
ROCE(5y)4.91%
ROICexgc growth 3Y-8.13%
ROICexgc growth 5Y-18.97%
ROICexc growth 3Y-4.98%
ROICexc growth 5Y-24.03%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 22.08%
Cap/Sales 1.47%
Interest Coverage 250
Cash Conversion 132.03%
Profit Quality 456.43%
Current Ratio 3.24
Quick Ratio 3.04
Altman-Z 11.23
F-Score6
WACC9.18%
ROIC/WACC0.23
Cap/Depr(3y)51.87%
Cap/Depr(5y)76.84%
Cap/Sales(3y)3.95%
Cap/Sales(5y)5.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.23%
EPS 3Y3.23%
EPS 5Y-6.99%
EPS Q2Q%15.79%
EPS Next Y2.56%
EPS Next 2Y9.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.11%
Revenue Next Year4.87%
Revenue Next 2Y5.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-24.4%
EBIT growth 3Y-14.15%
EBIT growth 5Y-20.42%
EBIT Next Year63.4%
EBIT Next 3Y26.27%
EBIT Next 5YN/A
FCF growth 1Y32.02%
FCF growth 3Y48.42%
FCF growth 5Y4.96%
OCF growth 1Y13.3%
OCF growth 3Y12.13%
OCF growth 5Y-7.69%

PROTO LABS INC / PRLB FAQ

Can you provide the ChartMill fundamental rating for PROTO LABS INC?

ChartMill assigns a fundamental rating of 4 / 10 to PRLB.


What is the valuation status of PROTO LABS INC (PRLB) stock?

ChartMill assigns a valuation rating of 1 / 10 to PROTO LABS INC (PRLB). This can be considered as Overvalued.


What is the profitability of PRLB stock?

PROTO LABS INC (PRLB) has a profitability rating of 3 / 10.


What is the financial health of PROTO LABS INC (PRLB) stock?

The financial health rating of PROTO LABS INC (PRLB) is 8 / 10.


Can you provide the expected EPS growth for PRLB stock?

The Earnings per Share (EPS) of PROTO LABS INC (PRLB) is expected to grow by 2.56% in the next year.